Home » Topics » Regulatory » Patents

Patents
RSS

Eisai presents compounds for cognitive disorders

Sep. 18, 2020

Autobahn Therapeutics synthesizes new TR-beta agonists

Sep. 18, 2020

Researchers discloses EFdA prodrugs for HIV infections

Sep. 18, 2020

Institute of Organic Chemistry and Biochemistry of the ASCR divulges hSTING agonists

Sep. 18, 2020

University of California discovers 5-HT2A receptor modulators

Sep. 17, 2020

Ferro Therapeutics patents new GPX4 inhibitors

Sep. 17, 2020

Chinese researchers present exportin-1 receptor antagonists

Sep. 17, 2020

Chaluesheng Medical Technology divulges RET inhibitors

Sep. 17, 2020

AstraZeneca discloses KRAS mutant inhibitors

Sep. 17, 2020

Sec61 protein secretion-interfering compounds presented by Kezar Life Sciences

Sep. 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...